SECTOR GAMMA AS
Adviser information for SECTOR GAMMA AS last updated from Form ADV on April 18th, 2023. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Corporation |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Norway |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
KRISTIAN AUGUSTS GATE 15COSLO
Norway
Monday - Friday, 0845-1600 (CET)
Tel: +47 23 01 29 00, Fax: +47 23 01 29 01
Chief Compliance Officer
TROND HORNELAND
CHIEF EXECUTIVE OFFICER/DIRECTOR
KRISTIAN AUGUSTS GATE 15C
P.O. BOX 462 SENTRUM
OSLO
Norway
Tel:
004723012900
Fax:
004723012901
C*********@********O
(Full email address available in API data)
Industry Affiliates
| None |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| SECTOR HEALTHCARE FUND, SUB-FUND OF SECTOR GAMMA INVESTMENT FUNDS PLC | Hedge Fund | $78.0M | $0.1M | 43 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| HORNELAND, TROND | Individual | – | CHIEF EXECUTIVE OFFICER AND DIRECTOR | 11/2006 | 25-50% |
| RASMUSSEN, DAG, ERIK | Individual | – | CHAIRMAN | 10/2009 | < 5% |
| ETHO AS | Foreign Entity | – | SHAREHOLDER | 11/2006 | 50-75% |
| SECTOR ASSET MANAGEMENT AS | Foreign Entity | – | SHAREHOLDER | 11/2006 | 25-50% |
| HORNELAND, TROND | Individual | ETHO AS | SHAREHOLDER | 10/2006 | > 75% |
| WOLLERT, HVIDE | Individual | – | DIRECTOR | 03/2012 | 25-50% |
| HERLOFSEN, ANDRE | Individual | – | DIRECTOR | 11/2014 | < 5% |
| VISTVEN, VEGARD | Individual | – | DIRECTOR | 03/2021 | < 5% |
| PRIEREN AS | Foreign Entity | SECTOR ASSET MANAGEMENT AS | OWNER IN SECTOR ASSET MANAGEMENT AS | 12/2005 | 25-50% |
| HVIDE, WOLLERT | Individual | PRIEREN AS | OWNER IN PRIEREN AS | 12/2005 | > 75% |
| HVIDE, MARTHEA, KYRKJEBOE | Individual | PRIEREN AS | OWNER IN PRIEREN AS | 12/2005 | > 75% |
| KYRKJEBOE, BRIT | Individual | PRIEREN AS | OWNER IN PRIEREN AS | 12/2005 | > 75% |
No. Employees, Historic
Holdings
From latest 13F, filed August 9th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ABBOTT LABS | COM | 7M | 70K | – |
| AGIOS PHARMACEUTICALS INC | COM | 5M | 122K | – |
| ALKERMES PLC | SHS | 5M | 194K | – |
| ALNYLAM PHARMACEUTICALS INC | COM | 4M | 15K | – |
| AMGEN INC | COM | 9M | 30K | – |
| BAXTER INTL INC | COM | 9M | 260K | – |
| BIOGEN INC | COM | 10M | 44K | – |
| BIO RAD LABS INC | CL A | 5M | 17K | – |
| BIOMARIN PHARMACEUTICAL INC | COM | 5M | 63K | – |
| BRISTOL-MYERS SQUIBB CO | COM | 22M | 535K | – |
| BRUKER CORP | COM | 7M | 115K | – |
| CARDINAL HEALTH INC | COM | 11M | 107K | – |
| CENTENE CORP DEL | COM | 3M | 45K | – |
| CVS HEALTH CORP | COM | 13M | 220K | – |
| ELEVANCE HEALTH INC | COM | 13M | 24K | – |
| EDWARDS LIFESCIENCES CORP | COM | 6M | 69K | – |
| GE HEALTHCARE TECHNOLOGIES I | COMMON STOCK | 8M | 104K | – |
| GILEAD SCIENCES INC | COM | 29M | 420K | – |
| INCYTE CORP | COM | 12M | 203K | – |
| IONIS PHARMACEUTICALS INC | COM | 8M | 170K | – |
| LANTHEUS HLDGS INC | COM | 3M | 32K | – |
| MEDTRONIC PLC | SHS | 21M | 265K | – |
| PFIZER INC | COM | 25M | 895K | – |
| QIAGEN NV | SHS NEW | 3M | 83K | – |
| TENET HEALTHCARE CORP | COM NEW | 7M | 53K | – |
| UNIVERSAL HLTH SVCS INC | CL B | 6M | 35K | – |
| VIATRIS INC | COM | 1M | 103K | – |
| ZIMMER BIOMET HOLDINGS INC | COM | 9M | 85K | – |